Federated Hermes
FHI NYSE Asset Management & Custody Banks Financials FY2016βFY2025
Federated Hermes' revenue rose 10.3% to $1.8 billion in fiscal 2025. Its operating margin was 28.5%, up from 22.1% a year earlier. Free cash flow was $295 million, down 14.0%. It paid out $368 million in dividends and buybacks, 125% of free cash flow. The diluted share count fell 5.5%.
What Federated Hermes does
No business description yet.
- Legal name
- Federated Hermes, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001056288-26-000007
0001056288
Revenue and margins
Federated Hermes had $1.8B of revenue in fiscal 2025, up 10.3% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 10.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $295M in fiscal 2025, 16.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Federated Hermes returned $368M to shareholders in fiscal 2025, 125% of free cash flow. The diluted share count fell 5.5%.
Value Federated Hermes yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $234M and divides by 75.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 10.6x Β· peers 18.0x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Federated Hermes can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $233M | $337M | $383M | $504M | $583M |
| Debt incl. finance leases | $223M | $348M | $348M | $348M | $348M |
| Net debt / EBITDA | β0.0x | 0.0x | β0.1x | β0.4x | β0.4x |
| Debt / equity | 0.2x | 0.3x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 205.2x | 30.4x | 31.0x | 28.5x | 40.4x |
| Current ratio | 2.1x | 2.5x | 2.5x | 2.7x | 2.8x |
| Quick ratio | 2.1x | 2.5x | 2.5x | 2.7x | 2.8x |
| Total assets | $2.0B | $2.0B | $2.1B | $2.1B | $2.2B |
| Total liabilities | $841M | $913M | $948M | $934M | $966M |
| Shareholders' equity | $1.1B | $1.0B | $1.1B | $1.1B | $1.2B |
| Net debt (β = net cash) | β$10.0M | $10.8M | β$35.4M | β$156M | β$234M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$8.8M
6 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Peter J GermainEVP, CLO & Sec. | Sold | 5,000 | $63.17 | $0.3M | Form 4 |
| Aug 4, 2026 | Saker Anwar NusseibehCEO, Federated Hermes Limited | Sold | 7,030 | $64.24 | $0.5M | Form 4 |
| Jun 23, 2026 | Meter Stephen VanVP, Chief Compliance Officer | Sold | 1,682 | $59.64 | $0.1M | Form 4 |
| Jun 16, 2026 | Paul A UhlmanVice President | Sold | 6,145 | $58.67 | $0.4M | Form 4 |
| Jun 8, 2026 | Saker Anwar NusseibehCEO, Federated Hermes Limited | Sold | 8,950 | $57.34 | $0.5M | Form 4 |
| May 26, 2026 | Paul A UhlmanVice President | Sold | 1,021 | $55.31 | $0.1M | Form 4 |
| May 26, 2026 | Peter J GermainEVP, CLO & Sec. | Sold | 409 | $55.31 | $0.0M | Form 4 |
| May 15, 2026 | Peter J GermainEVP, CLO & Sec. | Sold | 5,000 | $54.30 | $0.3M | Form 4 |
| May 7, 2026 | Bryan M BurkeVice President | Sold | 4,000 | $54.20 | $0.2M | Form 4 |
| Mar 13, 2026 | Thomas R DonahueVP, CFO & Treasurer, Director | Sold | 30,000 | $57.10 | $1.7M | Form 4 |
| Mar 12, 2026 | Paul A UhlmanVice President | Sold | 72,392 | $56.23 | $4.1M | Form 4 |
| Mar 5, 2026 | Paul A UhlmanVice President | Sold | 11,739 | $56.53 | $0.7M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 8 | 6 / 8 | 7 / 8 |
| Accruals ratio | β0.6% | β3.7% | 4.9% |
| Altman Z'' | 5.69 | 5.91 | 6.71 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Federated Hermes FHI | $4.1B | 10.3% | 28.5% | 16.4% | 40.9% | 10.6x | 7 | |
| Affiliated Managers Group AMG | $10.3B | 1.6% | β | 46.6% | 16.5% | 13.4x | β | Compare β |
| SEI Investments SEIC | $12.6B | 8.1% | 27.3% | 25.5% | β | 18.0x | β | Compare β |
| Blue Owl Capital OWL | $6.4B | 25.0% | β | 41.8% | 5.2% | 78.0x | β | Compare β |
| Hamilton Lane HLNE | β | 6.5% | β | 55.2% | 34.5% | β | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.1B | $1.1B | $1.1B | $1.3B | $1.4B | $1.3B | $1.4B | $1.6B | $1.6B | $1.8B |
| Operating income | $336M | $342M | $330M | $348M | $418M | $366M | $337M | $388M | $362M | $514M |
| Interest expense | $4.2M | $4.8M | $5.9M | $5.0M | $2.7M | $1.8M | $11.1M | $12.5M | $12.7M | $12.7M |
| Pretax income | $341M | $352M | $296M | $365M | $446M | $376M | $306M | $411M | $382M | $548M |
| Income tax | $119M | $57.1M | $73.9M | $88.1M | $110M | $104M | $71.7M | $107M | $113M | $133M |
| Net income | $209M | $291M | $220M | $272M | $326M | $270M | $240M | $299M | $268M | $403M |
| Diluted EPS | $2.03 | $2.87 | $2.18 | $2.69 | $3.23 | $2.75 | $2.65 | $3.40 | $3.23 | $5.13 |
| Diluted shares | 0.10B | 0.10B | 0.10B | 0.10B | 0.10B | 0.09B | 0.09B | 0.08B | 0.08B | 0.08B |
| Cash flow | ||||||||||
| Cash from operations | $266M | $387M | $206M | $335M | $373M | $170M | $324M | $312M | $347M | $297M |
| Capital expenditure | $12.8M | $9.8M | $17.3M | $15.0M | $13.5M | $10.4M | $4.4M | $7.9M | $4.0M | $2.8M |
| Free cash flow | $253M | $378M | $189M | $320M | $360M | $160M | $320M | $304M | $343M | $295M |
| Depreciation and amortization | $9.7M | $10.6M | $17.1M | $24.0M | $29.8M | $29.2M | $27.6M | $26.9M | $22.1M | $22.0M |
| Stock-based compensation | $22.4M | $22.5M | $23.9M | $25.1M | $26.7M | $30.3M | $34.8M | $33.9M | $28.8M | $29.1M |
| Acquisitions | $0.0M | $4.4M | $168M | $0.8M | $2.7M | $0.0M | $28.1M | $0.0M | $0.0M | $12.8M |
| Share buybacks | $81.8M | $48.6M | $29.2M | $15.7M | $66.8M | $228M | $218M | $177M | $138M | $263M |
| Dividends paid | $206M | $102M | $107M | $109M | $208M | $106M | $97.9M | $98.1M | $185M | $105M |
| Dividends and buybacks | $287M | $150M | $136M | $125M | $275M | $334M | $316M | $275M | $322M | $368M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $105M | $316M | $157M | $249M | $302M | $233M | $337M | $383M | $504M | $583M |
| Total debt | β | β | β | β | β | $223M | $348M | $348M | $348M | $348M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $360M | $437M | $304M | $461M | $575M | $559M | $651M | $721M | $781M | $864M |
| Current liabilities | $163M | $129M | $181M | $231M | $265M | $271M | $257M | $287M | $289M | $314M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $39.3M | $37.7M | $53.2M | $51.7M | $52.6M | $47.0M | $35.7M | $30.7M | $25.6M | $24.8M |
| Total assets | $1.2B | $1.2B | $1.5B | $1.9B | $2.1B | $2.0B | $2.0B | $2.1B | $2.1B | $2.2B |
| Total liabilities | $528M | $440M | $504M | $627M | $687M | $841M | $913M | $948M | $934M | $966M |
| Shareholders' equity | $595M | $761M | $857M | $1.0B | $1.1B | $1.1B | $1.0B | $1.1B | $1.1B | $1.2B |
| Margins | ||||||||||
| Operating margin | 29.4% | 31.0% | 29.1% | 26.2% | 28.9% | 28.2% | 23.3% | 24.1% | 22.2% | 28.5% |
| EBITDA margin | 30.2% | 31.9% | 30.6% | 28.0% | 30.9% | 30.4% | 25.2% | 25.8% | 23.5% | 29.8% |
| Net margin | 18.3% | 26.4% | 19.4% | 20.5% | 22.5% | 20.8% | 16.6% | 18.6% | 16.4% | 22.4% |
| FCF margin | 22.1% | 34.2% | 16.6% | 24.1% | 24.8% | 12.3% | 22.1% | 18.9% | 21.0% | 16.4% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | 23.9% | 26.7% | 25.0% | 40.9% |
| Return on capital employed | 33.2% | 32.6% | 26.8% | 23.1% | 24.3% | 20.7% | 19.2% | 21.7% | 20.0% | 27.7% |
| Return on equity | 33.6% | 43.0% | 27.2% | 28.7% | 30.0% | 24.0% | 22.2% | 27.5% | 24.1% | 35.2% |
| Return on assets | 17.8% | 24.4% | 15.9% | 15.9% | 16.6% | 13.3% | 11.9% | 14.5% | 12.8% | 18.7% |
| Growth | ||||||||||
| Revenue growth | 23.4% | β3.5% | 3.0% | 16.8% | 9.2% | β10.2% | 11.2% | 11.3% | 1.4% | 10.3% |
| Net income growth | 23.0% | 39.5% | β24.4% | 23.6% | 19.8% | β17.2% | β11.4% | 24.8% | β10.3% | 50.3% |
| EPS growth | 25.3% | 41.4% | β24.0% | 23.4% | 20.1% | β14.9% | β3.6% | 28.3% | β5.0% | 58.8% |
| FCF growth | 11.3% | 49.3% | β49.9% | 69.3% | 12.5% | β55.5% | 99.8% | β4.9% | 12.7% | β14.0% |
| Share count change | β1.4% | β1.7% | β0.5% | 0.3% | β0.8% | β2.8% | β8.5% | β2.2% | β5.3% | β5.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β0.0x | 0.0x | β0.1x | β0.4x | β0.4x |
| Debt / equity | β | β | β | β | β | 0.2x | 0.3x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 80.4x | 71.6x | 56.1x | 69.1x | 156.1x | 205.2x | 30.4x | 31.0x | 28.5x | 40.4x |
| Current ratio | 2.2x | 3.4x | 1.7x | 2.0x | 2.2x | 2.1x | 2.5x | 2.5x | 2.7x | 2.8x |
| Quick ratio | 2.2x | 3.4x | 1.7x | 2.0x | 2.2x | 2.1x | 2.5x | 2.5x | 2.7x | 2.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.1% | 0.9% | 1.5% | 1.1% | 0.9% | 0.8% | 0.3% | 0.5% | 0.3% | 0.2% |
| Stock comp / revenue | 2.0% | 2.0% | 2.1% | 1.9% | 1.8% | 2.3% | 2.4% | 2.1% | 1.8% | 1.6% |
| Payouts / FCF | 113.6% | 39.8% | 72.1% | 39.0% | 76.3% | 208.9% | 98.9% | 90.5% | 94.1% | 124.8% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | β | β | 6.0 | 7.0 | 6.0 | 7.0 |
| Altman Z'' | 5.8 | 7.2 | 5.4 | 5.4 | 5.7 | 5.5 | 5.2 | 5.7 | 5.9 | 6.7 |
| Accruals ratio | β4.9% | β8.1% | 1.0% | β3.7% | β2.4% | 4.9% | β4.2% | β0.6% | β3.7% | 4.9% |
Source: SEC EDGAR XBRL filings (CIK 0001056288). Data updated October 18, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.